Catubig, Mercedita D.

HRN: 02-61-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/06/2025
CEFTRIAXONE 1G (VIAL)
02/06/2025
02/13/2025
IV
2gms
OD
UTI
Waiting Final Action 
02/18/2025
CIPROFLOXACIN 500MG (TAB)
02/18/2025
02/25/2025
PO
500mg
BID
Complicated Uti
Waiting Final Action 
02/18/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/18/2025
02/25/2025
IV
500mg
Q8
Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: